Literature DB >> 7667398

Mechanisms of cerebral vasospasm in subarachnoid haemorrhage.

D A Cook1.   

Abstract

Cerebrovascular spasm is a slowly developing constriction of the cerebral arteries, which frequently follows subarachnoid haemorrhage and is associated with considerable morbidity and mortality. The condition has been studied by use of models of subarachnoid haemorrhage in the whole animal and examination of isolated blood vessels or vascular smooth muscle cells in culture. The condition probably arises from the action of haemoglobin released from erythrocytes trapped in the subarachnoid clots, although the mechanism of action of haemoglobin remains uncertain. Systemic pharmacotherapy to avert or reverse vasospasm is still experimental.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667398     DOI: 10.1016/0163-7258(94)00080-m

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  12 in total

Review 1.  Novel mechanisms contributing to cerebral vascular dysfunction during chronic hypertension.

Authors:  C G Sobey; F M Faraci
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

2.  Fundamental increase in pressure-dependent constriction of brain parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane depolarization.

Authors:  Matthew A Nystoriak; Kevin P O'Connor; Swapnil K Sonkusare; Joseph E Brayden; Mark T Nelson; George C Wellman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

3.  Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage.

Authors:  Y Maeda; K Hirano; Y Kai; M Hirano; S O Suzuki; T Sasaki; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

Review 4.  Reactive oxygen species in the cerebral circulation: physiological roles and therapeutic implications for hypertension and stroke.

Authors:  Tamara M Paravicini; Grant R Drummond; Christopher G Sobey
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhage.

Authors:  Saema Ansar; Aida Maddahi; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2011-10-27       Impact factor: 3.288

6.  Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage.

Authors:  Xiang-Dong Zhu; Jing-Sen Chen; Feng Zhou; Qi-Chang Liu; Gao Chen; Jian-Min Zhang
Journal:  Crit Care       Date:  2011-11-29       Impact factor: 9.097

7.  Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mechanism and therapies.

Authors:  Chih-Lung Lin; Aaron S Dumont; John H Zhang; Mario Zuccarello; Carl Muroi
Journal:  Biomed Res Int       Date:  2014-09-08       Impact factor: 3.411

8.  Valproic Acid Reduces Vasospasm through Modulation of Akt Phosphorylation and Attenuates Neuronal Apoptosis in Subarachnoid Hemorrhage Rats.

Authors:  Chieh-Hsin Wu; Yi-Cheng Tsai; Tai-Hsin Tsai; Keng-Liang Kuo; Yu-Feng Su; Chih-Hui Chang; Chih-Lung Lin
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

9.  Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage.

Authors:  Xiang-Dong Zhu; Jing-Sen Chen; Feng Zhou; Qi-Chang Liu; Gao Chen; Jian-Min Zhang
Journal:  J Neuroinflammation       Date:  2012-08-11       Impact factor: 8.322

10.  Therapeutic effect of and mechanisms underlying the effect of miR-195-5p on subarachnoid hemorrhage-induced vasospasm and brain injury in rats.

Authors:  Tai-Hsin Tsai; Chih-Hui Chang; Szu-Huai Lin; Yu-Feng Su; Yi-Cheng Tsai; Sheau-Fang Yang; Chih-Lung Lin
Journal:  PeerJ       Date:  2021-06-22       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.